vs

Side-by-side financial comparison of Align Technology (ALGN) and NATURAL HEALTH TRENDS CORP (NHTC). Click either name above to swap in a different company.

Align Technology is the larger business by last-quarter revenue ($1.0B vs $9.7M, roughly 107.5× NATURAL HEALTH TRENDS CORP). Align Technology runs the higher net margin — 13.0% vs -6.0%, a 19.0% gap on every dollar of revenue. On growth, Align Technology posted the faster year-over-year revenue change (5.3% vs -10.1%). Align Technology produced more free cash flow last quarter ($187.3M vs $-964.0K). Over the past eight quarters, Align Technology's revenue compounded faster (2.5% CAGR vs -5.6%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

Sword Health is a digital health company that develops physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, and injury prevention. The company was founded in 2015 in Portugal by Virgílio Bento and Márcio Colunas. Its services include digital physical therapy with artificial intelligence (AI) integrated into the care model. As of 2024, Sword Health operates internationally, with offices in the United States, Ireland, and Portugal. The company has been valued at $3 bil...

ALGN vs NHTC — Head-to-Head

Bigger by revenue
ALGN
ALGN
107.5× larger
ALGN
$1.0B
$9.7M
NHTC
Growing faster (revenue YoY)
ALGN
ALGN
+15.4% gap
ALGN
5.3%
-10.1%
NHTC
Higher net margin
ALGN
ALGN
19.0% more per $
ALGN
13.0%
-6.0%
NHTC
More free cash flow
ALGN
ALGN
$188.2M more FCF
ALGN
$187.3M
$-964.0K
NHTC
Faster 2-yr revenue CAGR
ALGN
ALGN
Annualised
ALGN
2.5%
-5.6%
NHTC

Income Statement — Q4 2025 vs Q4 2025

Metric
ALGN
ALGN
NHTC
NHTC
Revenue
$1.0B
$9.7M
Net Profit
$135.8M
$-588.0K
Gross Margin
65.3%
72.9%
Operating Margin
14.8%
-6.5%
Net Margin
13.0%
-6.0%
Revenue YoY
5.3%
-10.1%
Net Profit YoY
30.8%
-434.1%
EPS (diluted)
$1.88
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGN
ALGN
NHTC
NHTC
Q4 25
$1.0B
$9.7M
Q3 25
$995.7M
$9.5M
Q2 25
$1.0B
$9.8M
Q1 25
$979.3M
$10.7M
Q4 24
$995.2M
$10.8M
Q3 24
$977.9M
$10.7M
Q2 24
$1.0B
$10.5M
Q1 24
$997.4M
$11.0M
Net Profit
ALGN
ALGN
NHTC
NHTC
Q4 25
$135.8M
$-588.0K
Q3 25
$56.8M
$-431.0K
Q2 25
$124.6M
$15.0K
Q1 25
$93.2M
$122.0K
Q4 24
$103.8M
$176.0K
Q3 24
$116.0M
$35.0K
Q2 24
$96.6M
$173.0K
Q1 24
$105.0M
$188.0K
Gross Margin
ALGN
ALGN
NHTC
NHTC
Q4 25
65.3%
72.9%
Q3 25
64.2%
73.7%
Q2 25
69.9%
73.9%
Q1 25
69.5%
73.6%
Q4 24
70.0%
74.2%
Q3 24
69.7%
74.1%
Q2 24
70.3%
74.2%
Q1 24
70.0%
73.4%
Operating Margin
ALGN
ALGN
NHTC
NHTC
Q4 25
14.8%
-6.5%
Q3 25
9.7%
-5.2%
Q2 25
16.1%
-3.4%
Q1 25
13.4%
-3.2%
Q4 24
14.5%
-3.9%
Q3 24
16.6%
-2.6%
Q2 24
14.3%
-2.3%
Q1 24
15.5%
-3.3%
Net Margin
ALGN
ALGN
NHTC
NHTC
Q4 25
13.0%
-6.0%
Q3 25
5.7%
-4.5%
Q2 25
12.3%
0.2%
Q1 25
9.5%
1.1%
Q4 24
10.4%
1.6%
Q3 24
11.9%
0.3%
Q2 24
9.4%
1.7%
Q1 24
10.5%
1.7%
EPS (diluted)
ALGN
ALGN
NHTC
NHTC
Q4 25
$1.88
$-0.05
Q3 25
$0.78
$-0.04
Q2 25
$1.72
$0.00
Q1 25
$1.27
$0.01
Q4 24
$1.40
$0.01
Q3 24
$1.55
$0.00
Q2 24
$1.28
$0.02
Q1 24
$1.39
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGN
ALGN
NHTC
NHTC
Cash + ST InvestmentsLiquidity on hand
$1.1B
$28.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.0B
$23.4M
Total Assets
$6.2B
$38.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGN
ALGN
NHTC
NHTC
Q4 25
$1.1B
$28.9M
Q3 25
$1.0B
$32.0M
Q2 25
$901.2M
$34.2M
Q1 25
$873.0M
$41.9M
Q4 24
$1.0B
$43.9M
Q3 24
$1.0B
$46.3M
Q2 24
$761.4M
$48.7M
Q1 24
$865.8M
$54.4M
Stockholders' Equity
ALGN
ALGN
NHTC
NHTC
Q4 25
$4.0B
$23.4M
Q3 25
$4.0B
$26.1M
Q2 25
$3.9B
$28.9M
Q1 25
$3.8B
$30.9M
Q4 24
$3.9B
$32.9M
Q3 24
$3.9B
$35.3M
Q2 24
$3.8B
$37.3M
Q1 24
$3.8B
$39.4M
Total Assets
ALGN
ALGN
NHTC
NHTC
Q4 25
$6.2B
$38.4M
Q3 25
$6.2B
$42.3M
Q2 25
$6.2B
$45.2M
Q1 25
$6.1B
$53.2M
Q4 24
$6.2B
$55.4M
Q3 24
$6.4B
$58.3M
Q2 24
$6.2B
$61.5M
Q1 24
$6.2B
$67.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALGN
ALGN
NHTC
NHTC
Operating Cash FlowLast quarter
$223.2M
$-959.0K
Free Cash FlowOCF − Capex
$187.3M
$-964.0K
FCF MarginFCF / Revenue
17.9%
-9.9%
Capex IntensityCapex / Revenue
3.4%
0.1%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$490.8M
$-6.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALGN
ALGN
NHTC
NHTC
Q4 25
$223.2M
$-959.0K
Q3 25
$188.7M
$113.0K
Q2 25
$128.7M
$-5.6M
Q1 25
$52.7M
$484.0K
Q4 24
$286.1M
$88.0K
Q3 24
$263.7M
$-436.0K
Q2 24
$159.8M
$-3.6M
Q1 24
$28.7M
$549.0K
Free Cash Flow
ALGN
ALGN
NHTC
NHTC
Q4 25
$187.3M
$-964.0K
Q3 25
$169.0M
$70.0K
Q2 25
$107.2M
$-5.6M
Q1 25
$27.4M
$468.0K
Q4 24
$263.1M
$68.0K
Q3 24
$233.9M
$-443.0K
Q2 24
$106.4M
$-3.6M
Q1 24
$19.3M
$538.0K
FCF Margin
ALGN
ALGN
NHTC
NHTC
Q4 25
17.9%
-9.9%
Q3 25
17.0%
0.7%
Q2 25
10.6%
-57.5%
Q1 25
2.8%
4.4%
Q4 24
26.4%
0.6%
Q3 24
23.9%
-4.1%
Q2 24
10.3%
-34.2%
Q1 24
1.9%
4.9%
Capex Intensity
ALGN
ALGN
NHTC
NHTC
Q4 25
3.4%
0.1%
Q3 25
2.0%
0.5%
Q2 25
2.1%
0.0%
Q1 25
2.6%
0.1%
Q4 24
2.3%
0.2%
Q3 24
3.0%
0.1%
Q2 24
5.2%
0.2%
Q1 24
0.9%
0.1%
Cash Conversion
ALGN
ALGN
NHTC
NHTC
Q4 25
1.64×
Q3 25
3.33×
Q2 25
1.03×
-375.67×
Q1 25
0.57×
3.97×
Q4 24
2.76×
0.50×
Q3 24
2.27×
-12.46×
Q2 24
1.66×
-20.62×
Q1 24
0.27×
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons